Stocks Health care CAPR
NASDAQ · Health careCapricor Therapeutics, Inc. (CAPR)
It posted a net loss of $129.4M. In fiscal 2025 capital spending exceeded operating cash flow by $72.7M. At June 30, 2026 it held $20.9M in cash. Its latest periodic report to the SEC is the quarterly report (10-Q) filed on August 14, 2026.
What Capricor Therapeutics, Inc. does
Capricor Therapeutics, Inc. is registered with the SEC under industry code SIC 2834 (Pharmaceutical Preparations). Its shares trade on NASDAQ under the ticker CAPR.
Revenue and profit by year
Key figures
| Fiscal year | Revenue | Net income | Diluted EPS | Free cash flow |
|---|---|---|---|---|
| 2025 | $0 | -$105M | -$2.26 | -$72.7M |
| 2024 | $22.3M | -$40.5M | -$1.15 | -$41.2M |
| 2023 | $25.2M | -$22.3M | -$0.83 | -$26.9M |
| 2022 | $2.6M | -$29M | -$1.18 | $2.9M |
| 2021 | $244.9K | -$20M | -$0.87 | -$18M |
| 2020 | $310.3K | -$13.7M | -$0.88 | -$10.6M |
Latest SEC filings
What Capricor Therapeutics, Inc. has filed recently, newest first. Each links to the original document on SEC EDGAR.
- September 14, 2026Passive stake (5% or more) SCHEDULE 13G
- August 24, 2026Other event 8-K
- August 19, 2026Passive stake (5% or more) SCHEDULE 13G
- August 14, 2026Quarterly report 10-Q · period to June 30, 2026
- August 14, 2026Passive stake changed SCHEDULE 13G/A
- August 13, 2026
- August 7, 2026Passive stake (5% or more) SCHEDULE 13G
- August 3, 2026Passive stake (5% or more) SCHEDULE 13G
- July 30, 2026Other event 8-K
- July 29, 2026Other event 8-K
Questions about CAPR
What does Capricor Therapeutics, Inc. do?
Capricor Therapeutics, Inc. is registered with the SEC under industry code SIC 2834 (Pharmaceutical Preparations). Its shares trade on NASDAQ under the ticker CAPR.
Is Capricor Therapeutics, Inc. profitable?
No. Over the twelve months to June 30, 2026 it reported a net loss of $129.4M.
When did Capricor Therapeutics, Inc. last report?
Its most recent periodic report is the quarterly report (10-Q) filed on August 14, 2026. It covers the period to June 30, 2026. Its newest filing of any kind is the passive stake (5% or more) from September 14, 2026.
Similar companies
Follow CAPR
Get an email when Capricor Therapeutics, Inc. files with the SEC: results, executive changes, material agreements and annual reports.
Follow CAPR: get an email when it filesWhere the numbers come from
Financial figures are the values Capricor Therapeutics, Inc. tagged in its own SEC filings (XBRL), taken from the latest filing for each period, so restatements replace older figures. Revenue, profit and cash flow are for full fiscal years unless marked as the last twelve months, which is the sum of the four most recent quarters. Where a company reports only the full year, the fourth quarter is the year minus the first three.
Prices are delayed end-of-day market data in the listing currency, and market cap moves with the price. P/E is shown only when earnings per share are positive. Nothing here is investment advice.